OKYO Pharma Announces Collaboration with Prof. Pedram Hamrah to Evaluate Proprietary Lead Compounds as Non-Opioid Analgesics Targeting G-Protein Coupled Receptors
LONDON–(BUSINESS WIRE)–OKYO Pharma Limited (LSE: OKYO), a biotechnology company developing targeted drugs for inflammatory dry eye diseases and chronic pain,…